Integrative molecular analysis of metastatic Merkel cell carcinoma to identify predictive biomarkers of response to avelumab.

被引：1
|
作者：
Georges, Sara
Shah, Parantu K.
Shapiro, Irina
Hicking, Christine
Lu, Lei
Hennessy, Meliessa
D'Angelo, Sandra P.
Cai, Ti
机构：
[1] EMD Serono Res & Dev Inc, Global Dev, Billerica, MA USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.9569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9569
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Lethal thrombocytopenia in a patient treated with avelumab for metastatic Merkel cell carcinoma
    Kratzsch, Dorothea
    Simon, Jan-Christoph
    Poenitzsch, Iris
    Ziemer, Mirjana
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 (01): : 73 - 75
  • [22] Avelumab in chemotherapy-refractory metastatic Merkel cell carcinoma: Subgroup analysis of efficacy.
    Kaufman, Howard L.
    Russell, Jeffrey
    Hamid, Omid
    Bhatia, Shailender
    Terheyden, Patrick
    D'Angelo, Sandra P.
    Shih, Kent C.
    Lebbe, Celeste
    Linette, Gerald P.
    Milella, Michele
    Brownell, Isaac
    Lewis, Karl D.
    Lorch, Jochen H.
    von Heydebreck, Anja
    Mahnke, Lisa
    Nghiem, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [23] Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
    Bharmal, Murtuza
    Kearney, Mairead
    Zheng, Ying
    Phatak, Hemant
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 349 - 359
  • [24] PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma
    Gaiser, Maria Rita
    Bongiorno, Michelle
    Brownell, Isaac
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 345 - 359
  • [25] Avelumab in Patients with metastatic Merkel Cell Carcinoma - A Question of the Length of the Therapy Interval?
    Boettjer, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 88 - 88
  • [26] Metastatic Merkel Cell Carcinoma in Patients with CLL - Therapeutic Success with Avelumab and Chlorambucil
    Duecker, P.
    Huening, S.
    Lorenzen, J.
    Nashan, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 90 - 90
  • [27] Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma?
    Glutsch, V.
    Kneitz, H.
    Goebeler, M.
    Gesierich, A.
    Schilling, B.
    ANNALS OF ONCOLOGY, 2019, 30 (10) : 1667 - 1668
  • [28] Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma
    Min, Sandy Tun
    Nordman, Ina I. C.
    Tran, Huy A.
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 639 - 643
  • [29] Complete response with neoadjuvant avelumab in Merkel cell carcinoma - A case report
    Abdallah, Nadine
    Nagasaka, Misako
    Chowdhury, Tahmida
    Raval, Kunil
    Hotaling, Jeffrey
    Sukari, Ammar
    ORAL ONCOLOGY, 2019, 99
  • [30] RETIFANLIMAB VS AVELUMAB IN PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA: A COST-UTILITY ANALYSIS IN ITALY
    Ghetti, G.
    Porta, C.
    Povero, M.
    Trimarchi, C.
    VALUE IN HEALTH, 2024, 27 (12) : S66 - S66
12345